The FDA has issued an alert to healthcare providers about the risk of a serious fungal infection which may develop in users of rheumatoid arthritis drugs Remicade, Humira, Enbrel and Cimzia. The agency indicates that new information will be added to the drugs’ black box warnings about the risk. Continued

